FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Daiichi Sankyo Pharma Development Benicar HCT Tablets Recall

Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/12

Daiichi Sankyo Pharma Development · Edison, NJ

Risk level
Class II
Reported by FDA
Aug 6, 2014
Recall ID
D-1507-2014
Check your lot numberHow we source this data

Summary

Daiichi Sankyo Pharma Development recalled Benicar HCT Tablets starting Jul 12, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1507-2014 on Aug 6, 2014. Reason: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping. Status: Terminated.

Why it was recalled

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.

Product description

Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/12.5 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-106-30

Lot numbers, UPCs & expiration codes

Lot #0002073 Exp - 12/31/2016

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1507-2014
Classification
Class II
Status
Terminated
Recall initiated
Jul 12, 2014
FDA report date
Aug 6, 2014
Quantity
86 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Daiichi Sankyo Pharma Development

Original FDA data

Every field from FDA enforcement report D-1507-2014, exactly as published.

Show all FDA fields
City
Edison
State
NJ
Status
Terminated
Country
United States
Event ID
68793
Address
399 Thornall St
Code information
Lot #0002073 Exp - 12/31/2016
Postal code
08837-2236
Report date
Aug 6, 2014
Product type
Drugs
Recall number
D-1507-2014
Classification
Class II
Recalling firm
Daiichi Sankyo Pharma Development
Product quantity
86 bottles
Termination date
Mar 16, 2015
Reason for recall
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/12.5 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-106-30
Distribution pattern
Nationwide
Recall initiation date
Jul 12, 2014
Initial firm notification
Telephone
Center classification date
Jul 31, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1507-2014, published Aug 6, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls